Home/Filings/4/0000908662-09-000320
4//SEC Filing

AMP-99 MANAGEMENT CO LLC 4

Accession 0000908662-09-000320

CIK 0001405197other

Filed

Oct 7, 8:00 PM ET

Accepted

Oct 8, 4:21 PM ET

Size

10.9 KB

Accession

0000908662-09-000320

Insider Transaction Report

Form 4
Period: 2009-10-06
Transactions
  • Sale

    Common Stock

    2009-10-06$19.00/sh6,945,946$131,972,97415,707,155 total(indirect: By LLC)
Transactions
  • Sale

    Common Stock

    2009-10-06$19.00/sh6,945,946$131,972,97415,707,155 total(indirect: By LLC)
Transactions
  • Sale

    Common Stock

    2009-10-06$19.00/sh6,945,946$131,972,97415,707,155 total(indirect: By LLC)
Transactions
  • Sale

    Common Stock

    2009-10-06$19.00/sh6,945,946$131,972,97415,707,155 total(indirect: By LLC)
Footnotes (2)
  • [F1]Talecris Holdings, LLC sold 27,052,632 shares of the Issuer's common stock in the Issuer's initial public offering. Following the sale, Talecris Holdings, LLC owns 61,175,236 shares of the Issuer's common stock.
  • [F2]Ampersand 1999 Limited Partnership ("Fund 1"), Ampersand 1999 Companion Fund Limited Partnership ("Fund 2"), Ampersand 2001 Limited Partnership ("Fund 3"), Ampersand 2001 Companion Fund Limited Partnership ("Fund 4"), and Ampersand Plasma Holdings, L.L.C. ("Fund 5") (collectively referred to as the "Funds"), own a 25.7% equity interest in Talecris Holdings, LLC. AMP-99 Management Company Limited Liability Company ("AMP-99 MC LLC") is the General Partner of Fund 1 and Fund 2, AMP-01 Management Company Limited Liability Company ("AMP-01 MC LLC") is the General Partner of Fund 3 and Fund 4, and Fund 3 is the Managing Member of Fund 5 (AMP-99 MC LLC, AMP-01 MC LLC and the Funds collectively referred to as the "Ampersand Entities"). Each of the Ampersand Entities disclaims beneficial ownership of the securities reported herein, except to the extent of its respective pecuniary interest.

Issuer

Talecris Biotherapeutics Holdings Corp.

CIK 0001405197

Entity typeother

Related Parties

1
  • filerCIK 0001244765

Filing Metadata

Form type
4
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:21 PM ET
Size
10.9 KB